Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

Also called NCT01644474

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01644474
  • EudraCT 2011-001424-38
Main results
  • Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial International journal of cardiology, 2014-09 DOI, PubMed 25037695
Other papers using this trial's data
  • ODYSSEY MONO: effect of alirocumab 75 mg subcutaneously every 2 weeks as monotherapy versus ezetimibe over 24 weeks Future cardiology, 2015 DOI, PubMed 25606700

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, Finland, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01644474. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-07 (actual). Results posted on 2015-11-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia
Acronym
ODYSSEY MONO
Condition
Hypercholesterolemia
Intervention (Drug)
Alirocumab
Intervention (Drug)
Ezetimibe
Intervention (Drug)
Placebo (for Alirocumab)
Intervention (Drug)
Placebo (for Ezetimibe)
Lead sponsor
Sanofi (class: industry)
Collaborator
Regeneron Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct01644474
Content hash
224fb9533e05bba90a883cc19fdfa48e7d1473f708f2e0b016644cbeb6e806b9